DLL4 expression is a prognostic marker and may predict gemcitabine benefit in resected pancreatic cancer., Drouillard, A, Puleo F, Bachet J B, Ouazzani S, Calomme Annabelle, Demetter P, Verset G, Van Laethem J L, and Maréchal R , Br J Cancer, 2016 Nov 08, Volume 115, Issue 10, (2016)